Belupo

Belupo Pharmaceuticals and Cosmetics Inc., established in 1971, is a leading Croatian pharmaceutical company with operations spanning 18 European countries. The company actively participates in the Pharmaceuticals and Healthcare industries, focusing on maintaining a robust position in both prescription (Rx) and over-the-counter (OTC) drug segments. Belupo is committed to the development and launch of new products, with a strategic emphasis on expanding its OTC portfolio both regionally and globally. Its long-term vision is to become a preeminent pharmaceutical entity within Central and Eastern Europe. Manufacturing has been a core competency since 1971, bolstered by significant greenfield investments, including new solid and semi-solid manufacturing plants completed in 2017, enhancing its production capabilities.

Belupo employs between 500 - 1,000 individuals and operates from a single primary location in Koprivnica, Croatia. The company consistently invests in its operational infrastructure to support its strategic growth initiatives. Recognizing the importance of its workforce, Belupo offers insights into its team, and interested parties can learn more by visiting Meet Belupo's team. This dedication to operational excellence and human capital development is integral to its strategic objective of expanding its market presence into Central and Eastern European (CEE) and Southeastern European (SEE) regions, including targeted expansion into CIS countries.

The company's mid-term strategic goals involve further penetration into CEE and SEE markets, alongside focused expansion into CIS countries. This expansion will be driven by a diversified product portfolio and a concentrated effort on several new therapeutic groups. Belupo's product range includes generic drugs, prescription and non-prescription medicines, supplements, cosmetics,View more...